Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Trilaciclib
Trade Name
Synonyms G1T28
Drug Descriptions

Trilaciclib (G1T28) is a small molecule that inhibits CDK4/6, resulting in reversible cell-cycle arrest, and potentially reduces myelosuppression induced by chemotherapeutics (PMID: 26826116, PMID: 31575503).

DrugClasses CDK4/6 Inhibitor 14
CAS Registry Number 1374743-00-6
NCIT ID C123281

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Carboplatin + Etoposide + Trilaciclib Atezolizumab Carboplatin Etoposide Trilaciclib 0 1
Avelumab + Trilaciclib Avelumab Trilaciclib 0 1
Carboplatin + Gemcitabine + Pembrolizumab + Trilaciclib Carboplatin Gemcitabine Pembrolizumab Trilaciclib 0 1
Carboplatin + Gemcitabine + Trilaciclib Carboplatin Gemcitabine Trilaciclib 0 3
Carboplatin + Paclitaxel + Trilaciclib Carboplatin Paclitaxel Trilaciclib 0 1
Cisplatin + Gemcitabine + Trilaciclib Cisplatin Gemcitabine Trilaciclib 0 1
Cyclophosphamide + Doxorubicin + Pembrolizumab + Trilaciclib Cyclophosphamide Doxorubicin Pembrolizumab Trilaciclib 0 1
Cyclophosphamide + Doxorubicin + Trilaciclib Cyclophosphamide Doxorubicin Trilaciclib 0 0
Docetaxel + Trilaciclib Docetaxel Trilaciclib 0 1
Lurbinectedin + Trilaciclib Lurbinectedin Trilaciclib 0 1
Pertuzumab + Trastuzumab + Trilaciclib Pertuzumab Trastuzumab Trilaciclib 0 1
Sacituzumab govitecan-hziy + Trilaciclib Sacituzumab govitecan-hziy Trilaciclib 0 1
Topotecan + Trilaciclib Topotecan Trilaciclib 1 1
Trilaciclib Trilaciclib 1 5


Additional content available in CKB BOOST